Imara to Webcast Conference Call of First Quarter 2021 Financial Results and Business Highlights
May 04 2021 - 7:00AM
Imara Inc. (Nasdaq: IMRA), a clinical-stage biopharmaceutical
company dedicated to developing and commercializing novel
therapeutics to treat patients suffering from rare inherited
genetic disorders of hemoglobin, today announced that the company
will host a conference call and live webcast on Tuesday, May 11,
2021 at 8:30 a.m. ET to discuss its financial results for the
quarter ended March 31, 2021 and review recent business highlights.
A live webcast will be available under “Events and
Presentations” in the Investors section of the company's website.
The conference call can be accessed by dialing 1 (833) 519-1307
(U.S. domestic) or +1 (914) 800-3873 (international) and referring
to conference ID 7598753. A replay of the webcast will be archived
on the Imara website following the presentation.
About ImaraImara Inc. is a clinical-stage
biotechnology company dedicated to developing and commercializing
novel therapeutics to treat patients suffering from rare inherited
genetic disorders of hemoglobin. Imara is currently advancing
IMR-687, a highly selective, potent small molecule inhibitor of
PDE9 that is an oral, once-a-day, potentially disease-modifying
treatment for sickle cell disease and beta-thalassemia. IMR-687 is
being designed to have a multimodal mechanism of action that acts
on red blood cells, white blood cells, adhesion mediators and other
cell types. For more information, please
visit www.imaratx.com.
Media Contact:Gina NugentTen Bridge
Communications617-460-3579gina@tenbridgecommunications.com
Investor Contact:Michael
Gray617-835-4061mgray@imaratx.com
IMARA (NASDAQ:IMRA)
Historical Stock Chart
From Aug 2024 to Sep 2024
IMARA (NASDAQ:IMRA)
Historical Stock Chart
From Sep 2023 to Sep 2024